Mitoquinone mesylate CAS#: 845959-50-4; 凯望编码 (ChemWhat Code): 1239761
Identification
| 英文名 | Mitoquinone mesylate |
| IUPAC Name | 10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl-triphenylphosphanium;methanesulfonate |
| 分子结构 |  |
| CAS编号 | 845959-50-4 |
| EINECS Number | No data available |
| MDL Number | MFCD30747833 |
| Beilstein Registry Number | No data available |
| 别名 | MitoQmitoquinone mesylatemitoquinone |
| 分子式 | C38H47O7PS |
| 分子量 | 678.814 |
| InChI | InChI=1S/C37H44O4P.CH4O3S/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32;1-5(2,3)4/h10-18,21-26H,4-9,19-20,27-28H2,1-3H3 ;1H3,(H,2,3,4)/q+1;/p-1 |
| InChI Key | GVZFUVXPTPGOQT-UHFFFAOYSA-M |
| Canonical SMILES | CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](c2ccccc2)(c3ccccc3)c4ccccc4.CS(=O)(=O)[O-] |
| Patent Information | ||
| Patent ID | Title | Publication Date |
| US2007/161609 | Use of mitochondrially targeted antioxidant in treatment and prevention of drug-induced liver disease | 2007 |
| WO2005/19232 | MITOQUINONE DERIVATIVES USED AS MITOCHONDRIALLY TARGETED ANTIOXIDANTS | 2005 |
Physical Data
| Appearance | Reddish brown paste |
| Solubility | Soluble in dimethyl sulfoxide. |
Spectra
| Description (NMR Spectroscopy) | Nucleus (NMR Spectroscopy) | Solvents (NMR Spectroscopy) |
| Chemical shifts | 1H | chloroform-d1 |
| Chemical shifts | 31p | chloroform-d1 |
| Description (Mass Spectrometry) |
| high resolution mass spectrometry (HRMS), spectrum |
| liquid chromatography mass spectrometry (LCMS), time-of-flight mass spectra (TOFMS), electrospray ionisation (ESI), spectrum |
Route of Synthesis (ROS)
| Conditions | Yield |
| With oxygen; Nitrogen dioxide In dichloromethane at 20℃; for 4 – 8h; | 94% |
Safety and Hazards
| Pictogram(s) |  |
| Signal | Warning |
| GHS Hazard Statements | H302-H315-H319 Information may vary between notifications depending on impurities, additives, and other factors. |
| Precautionary Statement Codes | P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330 (The corresponding statement to each P-code can be found at the GHS Classification page.) |
Other Data
| Transportation | NONH for all modes of transport |
| Store in cool & dry place, keep away from strong light and heat. | |
| HS Code | 294200 |
| Storage | Store in cool & dry place, keep away from strong light and heat. |
| Shelf Life | 2 year |
| Market Price | USD |
| Druglikeness | |
| Lipinski rules component | |
| 分子量 | 678.827 |
| logP | 9.933 |
| HBA | 7 |
| HBD | 0 |
| Matching Lipinski Rules | 2 |
| Veber rules component | |
| Polar Surface Area (PSA) | 118.18 |
| Rotatable Bond (RotB) | 15 |
| Matching Veber Rules | 1 |
| Use Pattern |
| Mitoxantrone Methanesulfonate is primarily used for cancer treatment. It is an antineoplastic (anticancer) agent classified as an anthraquinone antibiotic. The primary therapeutic uses include : Breast Cancer : Mitoxantrone is often used to treat advanced or metastatic breast cancer. Prostate Cancer : Particularly effective in treating hormone-refractory prostate cancer. Leukemia : It is used to treat certain types of leukemia, such as acute myeloid leukemia (AML). Lymphomas and Other Solid Tumors : Mitoxantrone may also be used in the treatment of certain lymphomas and other types of solid tumors. Multiple Sclerosis (MS): Mitoxantrone is occasionally used to treat relapsing or progressive forms of multiple sclerosis to slow the progression of the disease. This drug works by interfering with DNA synthesis and replication, thus inhibiting the growth of cancer cells. |
试剂采购 | |
| 没有试剂厂商? | 向凯望发送快速询价 |
| 想要被列为试剂厂商? (付费服务) | 点击这里联系凯望 |
认证生产商 | |
| 想要被列为认证生产商 (需要通过认证)? | 请下载并填写 这份表格并发邮件到approved-manufacturers@chemwhat.com |
其他供应商 | |
| Watson International Limited | 访问Watson官网 |
如需其他帮助，请联系我们 | |
| 联系我们获取其它信息或服务 | 点击这里联系凯望 |